Search research articles
Contact Us
Filters
Showing results (121-130 of 158) with videos related to
Page
of 16
Sort By:
Journal of the American Society of Nephrology : JASN
|
January 19, 2007
Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies
Colin A Hutchison, Paul Cockwell, Steven Reid, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 29, 2026
Post-Ictal Sleep Changes in Human Focal Epilepsy
Vaclav Kremen, Vladimir Sladky, Vaclav Gerla, et al.
Trials
|
October 3, 2020
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor
Samantha Hinsley, Katrina Walker, Debbie Sherratt, et al.
Epilepsy Research
|
August 8, 2017
Does accounting for seizure frequency variability increase clinical trial power?
Daniel M Goldenholz, Shira R Goldenholz, Robert Moss, et al.
BMC Nephrology
|
July 18, 2018
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Punit Yadav, Paul Cockwell, Mark Cook, et al.
Epilepsy & Behavior : E&B
|
November 3, 2019
Computer-assisted EEG diagnostic review for idiopathic generalized epilepsy
Shannon Clarke, Philippa J Karoly, Ewan Nurse, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 28, 2018
Clinical utility of EEG in diagnosing and monitoring epilepsy in adults
W O Tatum, G Rubboli, P W Kaplan, et al.
British Journal of Haematology
|
April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial
Steve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 5, 2022
Corrigendum to "Clinical utility of EEG in diagnosing and monitoring epilepsy in adults" [Clin. Neurophysiol. 129 (2018) 1056-1082]
W O Tatum, G Rubboli, P W Kaplan, et al.
Trials
|
March 9, 2018
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial
Alina Striha, A John Ashcroft, Anna Hockaday, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 158) with videos related to
Sort By:
Page
of 16
Journal of the American Society of Nephrology : JASN
|
January 19, 2007
Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies
Colin A Hutchison, Paul Cockwell, Steven Reid, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
January 29, 2026
Post-Ictal Sleep Changes in Human Focal Epilepsy
Vaclav Kremen, Vladimir Sladky, Vaclav Gerla, et al.
Trials
|
October 3, 2020
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor
Samantha Hinsley, Katrina Walker, Debbie Sherratt, et al.
Epilepsy Research
|
August 8, 2017
Does accounting for seizure frequency variability increase clinical trial power?
Daniel M Goldenholz, Shira R Goldenholz, Robert Moss, et al.
BMC Nephrology
|
July 18, 2018
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
Punit Yadav, Paul Cockwell, Mark Cook, et al.
Epilepsy & Behavior : E&B
|
November 3, 2019
Computer-assisted EEG diagnostic review for idiopathic generalized epilepsy
Shannon Clarke, Philippa J Karoly, Ewan Nurse, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 28, 2018
Clinical utility of EEG in diagnosing and monitoring epilepsy in adults
W O Tatum, G Rubboli, P W Kaplan, et al.
British Journal of Haematology
|
April 21, 2015
Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial
Steve Schey, Sarah R Brown, Avie-Lee Tillotson, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 5, 2022
Corrigendum to "Clinical utility of EEG in diagnosing and monitoring epilepsy in adults" [Clin. Neurophysiol. 129 (2018) 1056-1082]
W O Tatum, G Rubboli, P W Kaplan, et al.
Trials
|
March 9, 2018
The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial
Alina Striha, A John Ashcroft, Anna Hockaday, et al.
Page
of 16